Previous Close | 0.8500 |
Open | 0.8500 |
Bid | 0.3000 |
Ask | 3.0000 |
Strike | 125.00 |
Expire Date | 2024-12-20 |
Day's Range | 0.8500 - 0.8500 |
Contract Range | N/A |
Volume | |
Open Interest | 319 |
With the EnlivenHealth platform, Omnicell (OMCL) is gaining momentum with cross-selling and up-selling communication solutions to existing customers.
QIAGEN (QGEN) launches the new QIAseq Multimodal DNA/RNA Lib Kit, facilitating multiomic studies and advancing precision medicine.
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.